Experience in the management of real-world patients with chronic prurigo nodularis in a dermatology setting: results from the ECOSPIN Spanish survey-based study. [PDF]
Figueras-Nart I +2 more
europepmc +1 more source
IgE-defined endotypes reveal distinct clinical profiles of prurigo nodularis compared with atopic dermatitis: a multicenter study in China. [PDF]
Ling S +8 more
europepmc +1 more source
Efficacy and safety of nemolizumab in prurigo nodularis: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Vieira ACP +4 more
europepmc +1 more source
Targeting IL-31RA with nemolizumab in prurigo nodularis: a systematic review, GRADE-assessed meta-analysis, and trial sequential analysis of randomized controlled trials. [PDF]
Aldamen AO +9 more
europepmc +1 more source
Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross-Sectional Population-Based Analysis. [PDF]
Valdman-Grinshpoun Y +4 more
europepmc +1 more source
Treatment Patterns, Healthcare Utilization, and Related Costs for Prurigo Nodularis in Sweden. [PDF]
Von Kobyletzki L +5 more
europepmc +1 more source
The Efficacy and Safety of Nemolizumab in Patients with Prurigo Nodularis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Titou H.
europepmc +1 more source
Plasma cytokine profiling identifies early kidney injury and systemic inflammation in prurigo nodularis. [PDF]
Akiska YM +10 more
europepmc +1 more source
Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature. [PDF]
Li B +7 more
europepmc +1 more source
Nanostring Transcriptomic Analysis Highlights IL-6 Family and TGF-β Pathways in the Pathogenesis of Prurigo Nodularis. [PDF]
Akiska YM +14 more
europepmc +1 more source

